160 related articles for article (PubMed ID: 22151982)
1. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
3. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
Miyachi K; Fujita M; Tanaka N; Sasaki K; Sunagawa M
J Exp Clin Cancer Res; 2002 Jun; 21(2):269-75. PubMed ID: 12148588
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
6. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer.
Lin X; Gu J; Lu C; Spitz MR; Wu X
Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976
[TBL] [Abstract][Full Text] [Related]
7. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.
Hu H; Zhang Y; Zou M; Yang S; Liang XQ
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1407-14. PubMed ID: 20127252
[TBL] [Abstract][Full Text] [Related]
8. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
9. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer.
Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H
Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation.
Klapper W; Krams M; Qian W; Janssen D; Parwaresch R
Br J Cancer; 2003 Aug; 89(4):713-9. PubMed ID: 12915884
[TBL] [Abstract][Full Text] [Related]
11. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
[TBL] [Abstract][Full Text] [Related]
12. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
13. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
[TBL] [Abstract][Full Text] [Related]
14. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
15. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
16. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
17. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
18. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
19. [The change of telomere protein in BEAS-2B malignant transformation cell induced by coal tar pitch smoke extracts].
Wang W; Li ZT; Zhu HS; Zhao Y; Wang LX; Yan Z; L IS; Xu D; Wu WD; Wu YJ; Wu YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2011 Sep; 29(9):678-81. PubMed ID: 22356715
[TBL] [Abstract][Full Text] [Related]
20. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]